TrialAnnals of oncology : official journal of the European Society for Medical Oncology2017

Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial.

J Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.